Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE

SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Standard Dose
0.398GM;1.102GM
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE is listed in Drugs@FDA under application 079247 (ANDA).

Marketing status: Prescription Active ingredient SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE Form and strength TABLET;ORAL - 0.398GM;1.102GM Sponsor NOVEL LABS INC Submission history Latest submission status date: 2011-12-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE is listed in Drugs@FDA under application 079247 (ANDA). Marketing status: Prescription Active ingredient SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE Form and strength TABLET;ORAL - 0.398GM;1.102GM Sponsor NOVEL LABS INC Submission history Latest submission status date: 2011-12-30 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.